Delivery Order SPE2DB20D1100-SPE2DB25FD7F1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Memantine HCL 2 mg/mL solution in 360 mL quantities, with a contract ceiling value of $1,360.68. This competitively awarded, firm fixed price delivery order is scheduled for completion by July 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a $87,500 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562071682 memantine hydrochloride 5 mg tablets. The order is for 100 units to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by September 7, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform under the contract from September 6 through September 7, 2023. The Defense Logistics Agency...
- The Defense Logistics Agency awarded a $1.55 million firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561597862 memantine hydrochloride 10 mg tablets (60 count). The prime contractor will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 26, 2023 in support of Department of Defense requirements. Amerisourcebergen will perform under this delivery order issued against their Prime Vendor Next contract vehicle, through which DLA...
- The Defense Logistics Agency Troop Support Medical awarded a $7,750 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 60 tablets of 10 mg memantine hydrochloride. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania within a period of performance spanning August 10-11, 2023. No major subcontractors or set aside designations were identified. The delivery order...
- This contract award is for the delivery of Donepezil HCL 23 mg tablets to the Defense Logistics Agency (DLA). The $2,382.12 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of February 10, 2023 and was awarded on February 9, 2023. There is no set-aside designation mentioned. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
- This federal contract award, valued at $2,173.58, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $5,497.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of MS Continuous Release Tablets 30mg, with an ultimate completion date of July 31, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor that serves...
- The Defense Logistics Agency awarded a delivery order valued at $15,182.28 to AmerisourceBergen Drug Corp for the supply of Namzaric 28 mg-10 mg capsules (30-count) with an ultimate completion date of July 21, 2025. This is a firm fixed-price, non-set-aside contract performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement for pharmaceutical products supporting federal medical supply needs. This delivery order is issued...
- This federal contract award is for the delivery of 90-count tablets of Donepezil HCL 23 mg, a prescription medication used to treat Alzheimer's disease. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,433.44 and an ultimate completion date of October 20, 2023. This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,728.54, is for the delivery of Donepezil HCL 23 mg tablets. The contract is a Firm Fixed Price Delivery Order with a period of performance ending on March 12, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD7F1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,884.33 to AmerisourceBergen Drug Corp for the supply of Memantine HCl 2 mg/mL solution in 360 mL quantities. The contract employs firm fixed price pricing with no set-aside designation, indicating competitive award, and carries an ultimate completion date of July 31, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle running through December 2026 designed to provide comprehensive pharmaceutical support to military healthcare systems worldwide. Memantine HCl is a cognitive enhancement medication commonly prescribed for Alzheimer's disease and other neurodegenerative conditions, making this procurement consistent with the Department of Defense's medical supply requirements for military and veteran healthcare systems. AmerisourceBergen's role as a major pharmaceutical distributor and federal medical vendor positions the company to fulfill the Defense Logistics Agency's ongoing needs for specialty medications and medical supplies across multiple therapeutic domains. This transaction exemplifies the company's participation in routine pharmaceutical procurement under its broader framework agreement with DLA, which enables efficient fulfillment of federal medical supply demands through an established vendor relationship.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 7/30/25 |